Searched for
MANKIND PHARMA SHARE PRICE TARGET
Can HCC extend its rally? Technical charts point to further upside, says Kkunal V. Parar10 Jun, 2026, 07.00 AM IST- Trent forms bullish reversal pattern after 7-month consolidation: Ajit Mishra19 Jun, 2026, 07.00 AM IST
- RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)16 Jun, 2026, 07.30 PM IST
- India just lost to Taiwan because of just one company26 May, 2026, 07.28 PM IST
- Melody hype sends wrong Parle stock to upper circuit21 May, 2026, 06.56 PM IST
- Melody hype sends wrong Parle stock to upper circuit21 May, 2026, 06.54 PM IST
- Trendline breakout and strong support zone signal rally in Graphite India: Shivangi Sarda15 May, 2026, 07.00 AM IST
- Mankind Pharma IPO: Condom maker's Rs 4,326 crore IPO to hit the market next week21 Apr, 2023, 12.33 PM IST
- Mankind Pharma sets IPO price band of 1,026 to 1,080 rupees a share; to open on Apr 2519 Apr, 2023, 10.45 AM IST
- Mankind Pharma management on FY24 growth outlook, new launches and balance sheet09 May, 2023, 01.42 PM IST
- ‘That’s an absurd statement’: Sanders loses cool at RFK Jr. over his remark on prescription drugs23 Apr, 2026, 01.41 AM IST
- Mankind Pharma IPO: Should you subscribe?26 Apr, 2023, 02.52 PM IST
- ‘Show us the deals’: Warren hammers RFK Jr over ‘100% tariffs free’ Big pharma deals for TrumpRx23 Apr, 2026, 01.50 AM IST
- Tech Mahindra Press Conference | Q4 FY26 Results | Management Briefing | LIVE22 Apr, 2026, 05.27 PM IST
- Watch: Mankind Pharma looking to sell 15 per cent stake25 Sep, 2017, 09.19 PM IST
- Double-digit returns for most 2023 IPOs with some surpassing 50%16 Jun, 2023, 04.14 PM IST
- Stock Radar | Pharma stocks are back in action; Sun Pharma likely to hit fresh highs: Ruchit Jain26 Jul, 2024, 07.00 AM IST
- Stock Radar: Buy Sun Pharma for a target of Rs 918-935, recommends Ruchit Jain21 Sep, 2022, 12.15 PM IST
- Stock Radar | Resilience seen in defensive pharma space; Sun Pharma hits record high29 Jul, 2024, 07.00 AM IST
- Mankind stake sale: PE players Apax Partners, Carlyle emerge as front-runners01 Jan, 2018, 04.32 PM IST
Load More
